Peter Clark

Novo Nordisk

BIOGRAPHY

Dr. Peter Clark is the Head of Computational Drug Design at Novo Nordisk, leading multidisciplinary teams that integrate digital and experimental approaches to accelerate therapeutic discovery. With more than twenty years in the healthcare and life sciences industry, he oversees the use of advanced computational models from early research through clinical development.

Peter’s leadership bridges AI-driven innovations and biomedical engineering to enable faster, more precise drug development across therapeutic modalities, advancing differentiated medicines from concept to first-in-human trials.